| Schedule of Reclassifications and Error Corrections |
Statement of Operations Reclassifications
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
(In thousands) |
|
December 31, 2020 |
|
|
|
Operating expense: |
|
As Reported |
|
Adjustment |
|
As Revised |
|
% Change |
|
Cost of goods sold |
|
$ |
— |
|
211 |
|
$ |
211 |
|
100 |
% |
Research and Development |
|
|
2,444 |
|
(70) |
|
|
2,374 |
|
(3) |
% |
General and administrative |
|
|
5,806 |
|
(141) |
|
|
5,665 |
|
(2) |
% |
Total operating expenses |
|
$ |
8,250 |
|
|
|
$ |
8,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
(In thousands) |
|
December 31, 2020 |
|
|
|
Operating expense: |
|
As Reported |
|
Adjustment |
|
As Revised |
|
% Change |
|
Cost of goods sold |
|
$ |
— |
|
318 |
|
$ |
318 |
|
100 |
% |
Research and Development |
|
|
4,206 |
|
30 |
|
|
4,236 |
|
1 |
% |
General and administrative |
|
|
11,378 |
|
(348) |
|
|
11,030 |
|
(3) |
% |
|
|
$ |
15,584 |
|
|
|
$ |
15,584 |
|
|
|
Segment Reporting Reclassification
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported: |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2020 (in thousands) |
|
iBio, Inc. |
|
iBio CDMO |
|
Eliminations |
|
Total |
Cost of goods sold |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
Research and Development |
|
|
525 |
|
|
2,220 |
|
|
(301) |
|
|
2,444 |
General and administrative |
|
|
2,981 |
|
|
3,050 |
|
|
(225) |
|
|
5,806 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As Revised: |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2020 (in thousands) |
|
iBio, Inc. |
|
iBio CDMO |
|
Eliminations |
|
Total |
Cost of goods sold |
|
$ |
215 |
|
$ |
(4) |
|
$ |
— |
|
$ |
211 |
Research and Development |
|
|
373 |
|
|
2,302 |
|
|
(301) |
|
|
2,374 |
General and administrative |
|
|
2,971 |
|
|
2,919 |
|
|
(225) |
|
|
5,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported: |
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2020 (in thousands) |
|
iBio, Inc. |
|
iBio CDMO |
|
Eliminations |
|
Total |
Cost of goods sold |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
Research and Development |
|
|
867 |
|
|
3,858 |
|
|
(519) |
|
|
4,206 |
General and administrative |
|
|
5,653 |
|
|
6,180 |
|
|
(455) |
|
|
11,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As Revised: |
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2020 (in thousands) |
|
iBio, Inc. |
|
iBio CDMO |
|
Eliminations |
|
Total |
Cost of goods sold |
|
$ |
269 |
|
$ |
49 |
|
$ |
— |
|
$ |
318 |
Research and Development |
|
|
608 |
|
|
4,147 |
|
|
(519) |
|
|
4,236 |
General and administrative |
|
|
5,643 |
|
|
5,842 |
|
|
(455) |
|
|
11,030 |
|